PR93572

MIAMI LAKES, Fla., Dec. 10, 2021 /PRNewswire=KYODO JBN/ --

-- Globally recognized interventional cardiologist is the latest addition to a

growing leadership team

Cordis, a global cardiovascular technology company, today announced George

Adams, MD, MHS, MBA, FACC, FSCAI as Chief Medical Officer, furthering the

organization's mission to differentiate itself as a technological leader and

value-based global medical device company.

Photo - https://mma.prnewswire.com/media/1704164/NewPictureGeorgeAdamsMD.jpg  

Logo - https://mma.prnewswire.com/media/1703651/Cordis_logo_R___jpeg_Logo.jpg

"We are delighted to have Dr. Adams join our team as we continue to build the

new Cordis," said CEO Shar Matin. "His depth of expertise in the treatment of

both complex coronary and peripheral vascular disease will play a vital role in

furthering our mission to improve patient care at pace with cost-effective,

differentiated solutions that build on our legacy of innovation."

Dr. Adams comes to Cordis with a distinguished combination of clinical

practice, medical research, and product development experience. He is globally

recognized for his expertise in the treatment of peripheral vascular disease in

patients with critical limb ischemia (CLI) and treatment of coronary artery

disease in patients with acute coronary syndromes. He is involved in the

development of regional and national systems of care for the treatment of CLI,

ST-Elevation Myocardial Infarction (STEMI), and management of complex coronary

and peripheral vascular disease. He has a well-established network of peers and

associates who are viewed as key opinion leaders within the global

cardiovascular community.

Dr. Adams plays an integral role in global peer education. He strives to

advance the field of medicine through leadership and moderation of, as well as

participation in, numerous cardiovascular and peripheral vascular forums

spanning national and global platforms.

He is a sought-after speaker and well-published researcher, serving as primary

investigator for multiple clinical trials. He is certified by The American

Board of Internal Medicine in internal medicine and cardiovascular disease.

"It is with great honor and excitement that I join the Cordis team as Chief

Medical Officer," said Dr. Adams.  "I look forward to playing a role in

reinvigorating an incredible 62-year legacy.  I am grateful to be a part of the

future that Cordis is building with integrity and a vision for innovation."

About Cordis

Cordis is a worldwide leader in the development and manufacturing of

interventional cardiovascular technologies with a more than 60-year history of

pioneering breakthrough therapies to treat millions of patients. With a

reputation for clinical acumen, training, and services, Cordis established a

legacy of innovation in high-quality and minimally invasive cardiovascular

products and built a strong global footprint with operations in more than 60

countries around the world.

Contact:

Kurt Haggstrom, Vice President, Global Marketing

Phone: 949-244-7382

Email: kurt.haggstrom@cardinalhealth.com

SOURCE: Cordis